SEC Form D · Amendment · filed July 6, 2022
RECODE THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Oleg S. Nodelman · Menlo Park, CADirectorHelen S. Kim · Menlo Park, CADirectorRana S. Al-Hallaq · Menlo Park, CADirectorEdward S. Hurwitz · Menlo Park, CADirectorDavid S. Lockhart · Menlo Park, CAExecPeter A. Thompson · Menlo Park, CADirectorAlan S. Colowick · Menlo Park, CADirectorRakhshita S. Dhar · Menlo Park, CADirectorShehnaaz Suliman · Menlo Park, CAExec · DirectorDominic Bagnoli · DENVER, CODirectorJacek Siwicki · New York, NYDirectorMark Prather · DENVER, COExecAllen Foley · New York, NYDirectorKaren Mcginnis · San Diego, CADirectorRyan Drant · DENVER, CODirectorZachary Morrison · New York, NYExecCory A. Carlson · Seattle, WADirectorJeff Fenster · Vista, CADirectorMartin A. Klingel, Jr · Carmel, CADirectorWiley S. Becker · Durham, NCDirectorSabyr Bukeikhanov · San Diego, CADirectorRakhshita S. Dhar · Menlo Park, CADirectorShehnaaz Suliman · Menlo Park, CAExec · DirectorAlan S. Colowick · Menlo Park, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗